Article

Iinvezz.com on 2022-07-22 03:04

Is Abbott Laboratories stock a ‘buy’ after market-beating Q2 results?

Sand Hill's Brenda Vingiello on CNBC's "Halftime Report" revealed her outlook on Abbott Laboratories stock after strong Q2 results.

Brenda Vingiello

Related news

IShould you buy Home Depot stock after solid Q2 results?invezz.com
North America
IShould you buy Qualcomm shares after record Q2 results?invezz.com
Wall Street
Abbott: Q2 Earnings Snapshot Merced Sun-Star
Wall Street
IShould you buy Walgreens stock on market-beating Q1 results?invezz.com
North America
IPepsiCo stock climbs to a record high after market-beating Q2 results invezz.com
North America , Wall Street
IAnalyst on Home Depot’s Q2 results: “there will be a time to buy the stock”invezz.com
Wall Street
ITesla Q2 results: CFRA analyst says the stock is a ‘buy’ here invezz.com
China , North America
Will Abbott Stock Rise After Its Q2 Results?Forbes
Michigan
IAbbott Labs stock price forecast for Q3 after Q2 results invezz.com
Abbott
Bullish on Abbott Laboratories The Globe and Mail
INordstrom shares fall 8.0% despite market-beating Q2 results invezz.com
Wall Street
BHow to Play Abbott Laboratories Stock With Options barrons.com
Wall Street , Abbott , Egypt , El Alamein , Germany
IAbbott Laboratories beats Wall Street estimates in the fourth quarter invezz.com
United States , Wall Street
IIs BJ’s Wholesale stock a ‘buy’ after record Q2 results?invezz.com
North America
Abbott Laboratories Profit Grows 54%wsj.com
Victoria’s Secret Reports Consensus Beating 1Q22 Results; Maintain Buy Forbes
China , Ireland , Canada , Thailand , North America
Dolby Laboratories: Fiscal Q2 Earnings Snapshot thenewstribune.com
Wall Street
CCharter Q2 Results Echo Comcast’s, Beating Wall Street Expectations But Showing Rare Loss Of Broadband Subscribers centralrecorder.com
Wall Street